J. Pharm. Pharmacogn. Res., vol. 14, no. 4, Article ID 2746, Jul-Aug 2026.

DOI: https://doi.org/10.56499/jppres_14.4.2746

Original Article

Hepatoprotective activity of Uncaria gambir extract in CCl4-induced liver fibrosis associated with suppression of TIMP-1 and type I collagen

 

[Actividad hepatoprotectora del extracto de Uncaria gambir en un modelo de fibrosis hepática inducida por CCl₄, asociada a la disminución de la expresión de TIMP-1 y del colágeno tipo I]

 

Sri Ningsih1*, Nisrina Firdausi1, Erni Hernawati Purwaningsih2, Sri Widia A. Jusman3,4, Wahono Sumaryono5†, Lamhot Parulian Manalu6, Sjaikhurrizal El Muttaqien7, Tarwadi Tarwadi7, Muhammad Delwar Hussain8, Mohsin Kazi9,10**

 

1Research Center for Pharmaceutical Ingredients and Traditional Medicine, Health Research Organization, National Research and Innovation Agency (BRIN), Cibinong, Bogor 16915, Indonesia.

2Department of Pharmacy, Faculty of Medicine, Universitas Indonesia, Jl Salemba Raya 6, Jakarta Pusat, Indonesia.

3Department of Biochemistry & Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jl Salemba Raya 6, Jakarta Pusat, Indonesia.

4Center of Hypoxia and Oxidative Stress Studies, Faculty of Medicine, Universitas Indonesia, Jl Salemba Raya 6, Jakarta Pusat, Indonesia.

5†Faculty of Pharmacy, Pancasila University, Jl Srengseng Sawah, Jakarta, Indonesia.

6Research Center for Equipment Manufacturing Technology, National Research and Innovation Agency (BRIN), Puspiptek Area, South Tangerang, Indonesia.

7Research Center for Vaccine and Drugs, National Research and Innovation Agency (BRIN), Cibinong, Bogor 16915, Indonesia.

8Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Eastern Shore, Princess Anne, MD, 21853, USA.

9Department of Pharmaceutics, College of Pharmacy, POBOX 2457, King Saud University, Riyadh 11451, Saudi Arabia.

10Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Savar, Dhaka 1216, Bangladesh.

E-mail: *srin002@brin.go.id, **mkazi@ksu.edu.sa

 

Abstract

Context: Oxidative stress contributes to hepatic fibrosis by promoting hepatic stellate cell activation and extracellular matrix deposition. Uncaria gambir (Hunter) Roxb. (UG) contains catechin-rich polyphenols with antioxidant potential, but its effect on matrix-remodeling markers in liver fibrosis requires further clarification.

Aims: To evaluate the hepatoprotective and antifibrotic effects of an ethanolic extract of U. gambir wilted leaf (EDW) material in a CCl₄-induced rat model of liver fibrosis.

Methods: The extract was prepared from dried wilted leaf material using ethanol. Total phenolic and catechin contents were determined using the Folin–Ciocalteu assay and HPLC, respectively. Male Sprague–Dawley rats were assigned to normal control, CCl₄ control, comparator, and EDW-treated groups. EDW was administered at 65, 131, or 262 mg/kg BW. Serum liver biomarkers, hepatic MDA, histopathological changes, fibrosis area, pseudolobule formation, steatosis area, TIMP-1 expression, and type I collagen deposition were evaluated.

Results: CCl₄ administration increased serum liver biomarkers and hepatic MDA and caused marked histological liver injury. EDW treatment reduced hepatic MDA and improved histological architecture. The highest EDW dose was associated with reduced serum bilirubin, fibrosis area, pseudolobule number, steatosis area, TIMP-1 immunoreactivity, and type I collagen deposition compared with the CCl₄ control.

Conclusions: EDW was associated with hepatoprotective and antifibrotic effects in CCl₄-treated rats, possibly through attenuation of oxidative stress and reduced extracellular matrix accumulation. Direct measurement of MMP activity and fibrogenic signaling is required to confirm modulation of the MMP–TIMP axis.

Keywords: catechin; CCl4-induced liver fibrosis; hepatoprotection; TIMP-1; type I collagen; Uncaria gambir (Hunter) Roxb.

 
PDF Download
 

Resumen

Contexto: El estrés oxidativo contribuye a la fibrosis hepática mediante la activación de las células estrelladas hepáticas y la acumulación de matriz extracelular. Uncaria gambir (Hunter) Roxb. contiene polifenoles ricos en catequinas con potencial antioxidante.

Objetivos: Evaluar los efectos hepatoprotectores y antifibróticos de un extracto etanólico de hojas marchitas de U. gambir (EDW) en un modelo de fibrosis hepática inducida por CCl₄ en ratas.

Métodos: Se determinaron los contenidos de fenoles totales y catequinas mediante los métodos de Folin–Ciocalteu y HPLC, respectivamente. Ratas Sprague–Dawley macho fueron distribuidas en grupos control normal, control CCl₄, comparador y grupos tratados con EDW (65, 131 y 262 mg/kg). Se evaluaron biomarcadores hepáticos séricos, MDA hepático, cambios histopatológicos, área de fibrosis, pseudolóbulos, esteatosis, expresión de TIMP-1 y depósito de colágeno tipo I.

Resultados: La administración de CCl₄ aumentó los biomarcadores hepáticos y el MDA hepático, además de inducir daño histológico. El tratamiento con EDW redujo el MDA hepático y mejoró la arquitectura hepática. La dosis más alta disminuyó la bilirrubina sérica, el área de fibrosis, el número de pseudolóbulos, la esteatosis, la inmunorreactividad de TIMP-1 y el depósito de colágeno tipo I en comparación con el grupo control CCl.

Conclusiones: El EDW mostró efectos hepatoprotectores y antifibróticos en ratas tratadas con CCl₄, posiblemente mediante la reducción del estrés oxidativo y de la acumulación de matriz extracelular. Se requieren estudios adicionales para confirmar la participación del eje MMP–TIMP.

Palabras Clave: catequina; fibrosis hepática inducida por CCl₄; hepatoprotección; TIMP-1; colágeno tipo I; Uncaria gambir (Hunter) Roxb.

 
PDF Download
 
Citation Format: Ningsih S, Firdausi N, Purwaningsih EH, Jusman SWA, Sumaryono W, Manalu LP, Muttaqien SE, Tarwadi T, Hussain MD, Kazi M (2026) Hepatoprotective activity of Uncaria gambir extract in CCl4-induced liver fibrosis associated with suppression of TIMP-1 and type I collagen. J Pharm Pharmacogn Res 14(4): 2746. https://doi.org/10.56499/jppres_14.4.2746
 
References

Anggraini T, Tai A, Yoshino T, Itani T (2011) Antioxidative activity and catechin content of four kinds of Uncaria gambir extracts from West Sumatra, Indonesia. Afr J Biochem Res 5(1): 33–38.

Bancroft J, Stevens A (1982) Theory and Practice of Histological Techniques, 2nd edn. New York: Churchill Livingstone.

Bocca C, Protopapa F, Foglia B, Maggiora M, Cannito S, Parola M, Novo E (2022) Hepatic myofibroblasts: A heterogeneous and redox-modulated cell population in liver fibrogenesis. Antioxidants 11(7): 1278. https://doi.org/10.3390/antiox11071278

Boll M, Lutz WD, Becker E, Stampfl A (2001) Mechanism of carbon tetrachloride-induced hepatotoxicity hepatocellular damage by reactive carbon tetrachloride metabolites. Z Naturforsch C J Biosci 56(7–8): 649–659. https://doi.org/10.1515/znc-2001-7-826

Desdiani D, Rengganis I, Djauzi S, Setiyono A, Sadikin M, Jusman SWA, Siregar NC, Suradi S, Eyanoer PC (2022) Fibropreventive and antifibrotic effects of Uncaria gambir on rats with pulmonary fibrosis. Evid Based Complement Alternat Med 2022: 6721958. https://doi.org/10.1155/2022/6721958

Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS (2023) Global burden of liver disease: 2023 update. J Hepatol 79(2): 516–537. https://doi.org/10.1016/j.jhep.2023.03.017

Fahrudin F, Ningsih S, Wardhana HI, Hariwibowo DR, Hamida F (2020) The effectiveness of carbon tetrachloride (CCl4) dosage on rats (Rattus norvegicus L) as animal model liver fibrosis. Ber Biol 19(3B): 411–422. https://doi.org/10.14203/beritabiologi.v19i3B.3961

Hatano T, Taniguchi S, Kuroda K, Doi K, Tanabe M, Shibata T, Yoshida T (2008) Dimeric flavans from gambir and their structural correlations with (+)catechin. Heterocycles 76(2): 1171–1180. https://doi.org/10.3987/COM-08-S(N)76

Huang W, Zheng Y, Feng H, Ni L, Ruan Y, Zou X, Ye M, Zou S (2020) Total phenolic extract of Euscaphis konishii Hayata pericarp attenuates carbon tetrachloride (CCl4)-induced liver fibrosis in mice. Biomed Pharmacother 125: 109932. https://doi.org/10.1016/j.biopha.2020.109932

Inoue T, Ando K, Kikugawa K (1998) Specific determination of malonaldehyde by N-methyl‐2‐phenylindole or thiobarbituric acid. J Am Oil Chem Soc 75(5): 597–600. https://doi.org/10.1007/s11746-998-0071-2

Iredale JP, Thompson A, Henderson NC (2013) Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta 1832(7): 876–883. https://doi.org/10.1016/j.bbadis.2012.11.002

Irondi EA, Oboh G, Agboola SO, Boligon AA, Athayde ML (2016) Phenolics extract of Tetrapleura tetraptera fruit inhibits xanthine oxidase and Fe2+-induced lipid peroxidation in the kidney, liver, and lungs tissues of rats in vitro. Food Sci Hum Wellness 5(1): 17–23. https://doi.org/10.1016/j.fshw.2015.11.001

Ministry of Health of the Republic of Indonesia (2017) Indonesian Herbal Pharmacopoeia, 2nd edn. Jakarta: Ministry of Health.

Kuskunović S, Radović S, Dorić M, Hukić A, Babić M, Tomić I, Selak I (2009) Immunohistochemical expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in invasive breast carcinoma. Bosn J Basic Med Sci 9(2): 125–130. https://doi.org/10.17305/bjbms.2009.2831

Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y (2018) The potential and action mechanism of polyphenols in the treatment of liver diseases. Oxid Med Cell Longev 2018: 8394818. https://doi.org/10.1155/2018/8394818

Mallory FB (1942) Pathological Techniques. Philadelphia: WB Saunders.

Martínez S, Fuentes C, Carballo J (2022) Antioxidant activity, total phenolic content and total flavonoid content in sweet chestnut (Castanea sativa Mill.) cultivars grown in Northwest Spain under different environmental conditions. Foods 11(21): 3519. https://doi.org/10.3390/foods11213519

Mooli RGR, Mukhi D, Ramakrishnan SK (2022) Oxidative stress and redox signaling in the pathophysiology of liver diseases. Compr Physiol 12(2): 3167–3192. https://doi.org/10.1002/cphy.c200021

Munggari IP, Kurnia D, Deawati Y, Julaeha E (2022) Current research of phytochemical, medicinal and non-medicinal uses of Uncaria gambir Roxb.: A review. Molecules 27(19): 6551. https://doi.org/10.3390/molecules27196551

Ningsih S, Fachrudin F, Rismana E, Purwaningsih EH, Sumaryono S, Jusman SW (2014) Evaluation of antilipid peroxidation activity of gambir extract on liver homogenat in vitro. Int J PharmTech Res 6(3): 982–989.

Pane YS, Machrina Y, Hasan S, Lumongga F, Yunanda Y (2021) Natural product of gambier (Uncaria gambier Roxb) extracts to counter against hepatotoxicity effects due to monosodium glutamate induction in male mice. J Adv Pharm Technol Res 12(1): 104–108. https://doi.org/10.4103/japtr.JAPTR_268_20

Rismana E, Ningsih S, Fachrudin F (2017) In vitro study of xanthine oxidase inhibitory of gambir (Uncaria gambir) Hunter Roxb Extracts. Pharmacogn J 9(6): 862–865. https://doi.org/10.5530/pj.2017.6.135

Roehlen N, Crouchet E, Baumert TF (2020) Liver fibrosis: Mechanistic concepts and therapeutic perspectives. Cells 9(4): 875. https://doi.org/10.3390/cells9040875

Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K (2002) Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 9(3): 232–238. https://doi.org/10.1078/0944-7113-00119

Suparni, Musthari, Mutia L, Sinurat M, Syarifah S, Sedana D, Anggraini DR, Ichwan M (2020) The hepatoprotector effect of Uncaria gambir Roxb extract in Wistar rats induced by paracetamol. J Drug Delivery Ther 10(6): 61–66. https://doi.org/10.22270/jddt.v10i6-s.4457

Tsai CF, Hsu YW, Ting HC, Huang CF, Yen CC (2013) The in vivo antioxidant and antifibrotic properties of green tea (Camellia sinensis, Theaceae). Food Chem 136(3-4): 1337–1344. https://doi.org/10.1016/j.foodchem.2012.09.063

Wang FD, Zhou J, Chen EQ (2022) Molecular mechanisms and potential new therapeutic drugs for liver fibrosis. Front Pharmacol 13: 787748. https://doi.org/10.3389/fphar.2022.787748

Widiyarti G, Sundowo A, Hanafi M (2012) The free radical scavenging and anti-hyperglycemic activities of various gambiers available in Indonesian market. Makara J Sci 15(2): 129–134. https://doi.org/10.7454/mss.v15i2.1062

© 2026 Journal of Pharmacy & Pharmacognosy Research

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Site Update: October 25th, 2026

Made with ♥ by AVAGAX Studio